225 related articles for article (PubMed ID: 28215548)
21. Combination of CA19-9 and Blood Free-Circulating Methylated RUNX3 May Be Useful to Diagnose Stage I Pancreatic Cancer.
Fujimoto Y; Suehiro Y; Kaino S; Suenaga S; Tsuyama T; Matsui H; Higaki S; Fujii I; Suzuki C; Hoshida T; Matsumoto T; Takami T; Nagano H; Sakaida I; Yamasaki T
Oncology; 2021; 99(4):234-239. PubMed ID: 33440396
[TBL] [Abstract][Full Text] [Related]
22. Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method.
Zhou Y; Song R; Ma C; Zhou L; Liu X; Yin P; Zhang Z; Sun Y; Xu C; Lu X; Xu G
Oncotarget; 2017 Mar; 8(13):20719-20728. PubMed ID: 28157703
[TBL] [Abstract][Full Text] [Related]
23. Cortisol, cortisone, and 4-methoxyphenylacetic acid as potential plasma biomarkers for early detection of non-small cell lung cancer.
Xiang C; Jin S; Zhang J; Chen M; Xia Y; Shu Y; Guo R
Int J Biol Markers; 2018 Aug; 33(3):314-320. PubMed ID: 29896992
[TBL] [Abstract][Full Text] [Related]
24. The metabolic time line of pancreatic cancer: Opportunities to improve early detection of adenocarcinoma.
Moore HB; Culp-Hill R; Reisz JA; Lawson PJ; Sauaia A; Schulick RD; Del Chiaro M; Nydam TL; Moore EE; Hansen KC; D'Alessandro A
Am J Surg; 2019 Dec; 218(6):1206-1212. PubMed ID: 31514959
[TBL] [Abstract][Full Text] [Related]
25. Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma.
LaConti JJ; Laiakis EC; Mays AD; Peran I; Kim SE; Shay JW; Riegel AT; Fornace AJ; Wellstein A
BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S1. PubMed ID: 25923219
[TBL] [Abstract][Full Text] [Related]
26. Serum microRNA signatures and metabolomics have high diagnostic value in colorectal cancer using two novel methods.
Liu HN; Liu TT; Wu H; Chen YJ; Tseng YJ; Yao C; Weng SQ; Dong L; Shen XZ
Cancer Sci; 2018 Apr; 109(4):1185-1194. PubMed ID: 29363233
[TBL] [Abstract][Full Text] [Related]
27. Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer.
Hussein NA; Kholy ZA; Anwar MM; Ahmad MA; Ahmad SM
J Cancer Res Clin Oncol; 2017 Jan; 143(1):83-93. PubMed ID: 27631726
[TBL] [Abstract][Full Text] [Related]
28. Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis.
Xue A; Scarlett CJ; Chung L; Butturini G; Scarpa A; Gandy R; Wilson SR; Baxter RC; Smith RC
Br J Cancer; 2010 Jul; 103(3):391-400. PubMed ID: 20588270
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.
Urayama S
World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935
[TBL] [Abstract][Full Text] [Related]
30. Metabolomic profiling reveals potential biomarkers in esophageal cancer progression using liquid chromatography-mass spectrometry platform.
Zhang H; Wang L; Hou Z; Ma H; Mamtimin B; Hasim A; Sheyhidin I
Biochem Biophys Res Commun; 2017 Sep; 491(1):119-125. PubMed ID: 28711496
[TBL] [Abstract][Full Text] [Related]
31. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
[TBL] [Abstract][Full Text] [Related]
32. Novel serum metabolomics-based approach by gas chromatography/triple quadrupole mass spectrometry for detection of human skin cancers: Candidate biomarkers.
Fukumoto T; Nishiumi S; Fujiwara S; Yoshida M; Nishigori C
J Dermatol; 2017 Nov; 44(11):1268-1275. PubMed ID: 28593747
[TBL] [Abstract][Full Text] [Related]
33. Possibility of detecting intraductal papillary mucinous neoplasms using metabolite biomarkers for pancreatic cancer.
Nakano R; Nishiumi S; Kobayashi T; Ikegawa T; Kodama Y; Yoshida M
Biomark Med; 2020 Jul; 14(11):1009-1020. PubMed ID: 32940075
[No Abstract] [Full Text] [Related]
34. Cross-species antibody microarray interrogation identifies a 3-protein panel of plasma biomarkers for early diagnosis of pancreas cancer.
Mirus JE; Zhang Y; Li CI; Lokshin AE; Prentice RL; Hingorani SR; Lampe PD
Clin Cancer Res; 2015 Apr; 21(7):1764-71. PubMed ID: 25589628
[TBL] [Abstract][Full Text] [Related]
35. Comparing the diagnostic accuracy of five common tumour biomarkers and CA19-9 for pancreatic cancer: a protocol for a network meta-analysis of diagnostic test accuracy.
Ge L; Pan B; Song F; Ma J; Zeraatkar D; Zhou J; Tian J
BMJ Open; 2017 Dec; 7(12):e018175. PubMed ID: 29282264
[TBL] [Abstract][Full Text] [Related]
36. Serum peptide signatures for pancreatic cancer based on mass spectrometry: a comparison to CA19-9 levels and routine imaging techniques.
Velstra B; Vonk MA; Bonsing BA; Mertens BJ; Nicolardi S; Huijbers A; Vasen H; Deelder AM; Mesker WE; van der Burgt YE; Tollenaar RA
J Cancer Res Clin Oncol; 2015 Mar; 141(3):531-41. PubMed ID: 25240825
[TBL] [Abstract][Full Text] [Related]
37. A Panel of Three Biomarkers Identified by iTRAQ for the Early Diagnosis of Pancreatic Cancer.
Wu X; Zhang ZX; Chen XY; Xu YL; Yin N; Yang J; Zhu DM; Li DC; Zhou J
Proteomics Clin Appl; 2019 Sep; 13(5):e1800195. PubMed ID: 31025496
[TBL] [Abstract][Full Text] [Related]
38. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.
Hocker JR; Postier RG; Li M; Lerner MR; Lightfoot SA; Peyton MD; Deb SJ; Baker CM; Williams TL; Hanas RJ; Stowell DE; Lander TJ; Brackett DJ; Hanas JS
Cancer Lett; 2015 Apr; 359(2):314-24. PubMed ID: 25637792
[TBL] [Abstract][Full Text] [Related]
39. Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer.
Wang WS; Liu LX; Li GP; Chen Y; Li CY; Jin DY; Wang XL
Cancer Prev Res (Phila); 2013 Apr; 6(4):331-8. PubMed ID: 23430754
[TBL] [Abstract][Full Text] [Related]
40. RNA-Binding Motif Protein 6 is a Candidate Serum Biomarker for Pancreatic Cancer.
Duan B; Hu X; Fan M; Xiong X; Han L; Wang Z; Tong D; Liu L; Wang X; Li W; Yang J; Huang C
Proteomics Clin Appl; 2019 Sep; 13(5):e1900048. PubMed ID: 31207145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]